Literature DB >> 31692433

RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.

Hu Fen1, Zheng Hongmin2, Wei Wei1, Yang Chao1, Yao Yang1, Liu Bei1, Sun Zhihua1.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most deadly cancer types worldwide, and its incidence is high in China. Multiple long non-coding RNAs (lncRNAs) have been recently identified as crucial oncogenic factors or tumor suppressors. In this study, we explored the effects of LncRNA RHPN1 antisense RNA 1 (RHPN1-AS1) on the progression of HCC.
METHODS: Expression levels of RHPN1-AS1 and miR-596 in HCC samples were measured by qRT-PCR. The association between pathological indexes and the expression level of RHPN1-AS1 was also analyzed. Human HCC cell lines Huh7 and SMMC-7721 were used as cell models. CCK-8 and colony formation assays were performed to assess the effect of RHPN1-AS1 on HCC cell line proliferation. The flow cytometer instrument was used to study the effect of RHPN1-AS1 on apoptosis of HCC cells. The transwell assay was conducted to detect the effect of RHPN1-AS1 on migration and invasion. Furthermore, luciferase reporter assay was used to confirm targeting of miR-596 by RHPN1-AS1. Additionally, the regulatory function of RHPN1-AS1 on insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) was detected by western blot.
RESULTS: The expression level of RHPN1-AS1 in HCC samples was observed to significantly increase compared with normal tissues and its high expression was correlated with unfavorable pathological indexes. Highly expressed RHPN1-AS1 was associated with shorter overall survival time. RHPN1-AS1 overexpression remarkably accelerated proliferation and metastasis of HCC cells, while reduced apoptosis. Accordingly, RHPN1-AS1 knockdown suppressed the malignant phenotypes of HCC cells. RHPN1-AS1 overexpression significantly reduced miR-596 expression by sponging it, but enhanced IGF2BP2 expression.
CONCLUSION: RHPN1-AS1 acts as a sponge of tumor suppressor miR-596 in HCC that can indirectly enhance the IGF2BP2 expression and function as an oncogenic lncRNA. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  CCK-8; HCC; IGF2BP2; RHPN1-AS1; miR-596; oncogenic lncRNA.

Mesh:

Substances:

Year:  2020        PMID: 31692433     DOI: 10.2174/1381612825666191105104549

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

Review 1.  The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.

Authors:  Jinyan Wang; Lijuan Chen; Ping Qiang
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

2.  Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.

Authors:  Junrong Wang; Weimin Ding; Yingke Xu; Enfu Tao; Miaojun Mo; Wei Xu; Xu Cai; Xiaomin Chen; Junhui Yuan; Xiuying Wu
Journal:  Aging (Albany NY)       Date:  2020-03-12       Impact factor: 5.682

3.  Knockdown of LINC00473 Enhances Radiosensitivity in Hepatocellular Carcinoma via Regulating the miR-345-5p/FOXP1 Axis.

Authors:  Yuhong Zhang; Bo Huang; Zhi Chen; Shiming Yang
Journal:  Onco Targets Ther       Date:  2020-01-08       Impact factor: 4.147

4.  Integrative Analysis of Methylation and Copy Number Variations of Prostate Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis.

Authors:  Yaxin Hou; Junyi Hu; Lijie Zhou; Lilong Liu; Ke Chen; Xiong Yang
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

Review 5.  The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Bashdar Mahmud Hussen; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-21       Impact factor: 6.244

6.  RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.

Authors:  Shoubin Cui; Cui Li
Journal:  Oncol Rep       Date:  2021-04-28       Impact factor: 3.906

7.  Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A).

Authors:  Yi Zhou; Jing Li; Xiaoxin Yang; Yu Song; Haigang Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  The Involvement of Insulin-Like Growth Factor 2 Messenger Ribonucleic Acid-Binding Protein 2 in the Regulation of the Expression of Breast Cancer-Related Genes.

Authors:  Chao Gao; Li Li; Xixin Jin; Xinyu Song; Huiling Li; Xiaoli Xu; Chao Dong; Binlin Ma
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-10-10

9.  MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer.

Authors:  Yongyi Chen; Wangang Gong; Wumin Dai; Zhiwen Pan; Xiaohong Xu; Huifen Jiang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

10.  Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma.

Authors:  Jiaying Liang; Yaofeng Zhi; Wenhui Deng; Weige Zhou; Xuejun Li; Zheyou Cai; Zhijian Zhu; Jinxiang Zeng; Wanlan Wu; Ying Dong; Jin Huang; Yuzhuo Zhang; Shichao Xu; Yixin Feng; Fuping Ding; Jin Zhang
Journal:  PeerJ       Date:  2021-06-11       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.